Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B-Reference-Cited by-同舟云学术

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

Published:2012-03 Issue:3 Volume:142 Page:513-520.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sonneveld Milan J.,Wong Vincent W.–S.,Woltman Andrea M.,Wong Grace L.H.,Cakaloglu Yilmaz,Zeuzem Stefan,Buster Erik H.C.J.,Uitterlinden Andre G.,Hansen Bettina E.,Chan Henry L.Y.,Janssen Harry L.A.

Funder

Stichting voor Lever- en Maag-Darm Onderzoek

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Hepatocellular carcinoma and hepatitis B virus;Chan;Semin Liver Dis,2006

2. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone;Chan;Ann Intern Med,2005

3. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

4. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

5. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b;Buster;Gastroenterology,2008

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction Model for the Clearance of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B before Interferon Therapy: A Prospective Case–Control Study;Diagnostics;2024-01-04

2. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

3. Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2023-03-20

4. STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China;Journal of Medical Virology;2022-06

5. Relationship Between Interleukin-28B Gene Polymorphism and Chronic Hepatitis B Infection;Medical Records;2022-01-16